TSX News -
Petrus Announces Results of Annual General Meeting of Shareholders
CALGARY, Alberta, May 30, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company“) (TSX: PRQ) is pleased to […]
TSX News -
D-BOX Technologies’ Fourth Quarter Caps Record Year for Revenue and Net Profit
Haptics leader is focused on accelerating profitable growth MONTREAL, May 30, 2024 (GLOBE NEWSWIRE) — D-BOX Technologies Inc. (“D-BOX” or […]
CANADA CARBON FILES NI 43-101 REPORT ON SEDAR
Toronto, ON, Canada, May 30, 2024 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company”) (TSX-V:CCB), (FF:U7N1) reports that it has […]
Lithium Ionic Signs Agreement to Acquire Remaining 15% of Salinas Properties, Minas Gerais, Brazil
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the […]
TSX News -
Osisko Announces Results of Annual Meeting of Shareholders
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) — Osisko Mining Inc. (TSX:OSK “Osisko” or the “Corporation“) announces the results of its […]
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in […]
BurgerFi to Consider Strategic Alternatives
Designates David Heidecorn as successor to Ophir Sternberg as Chairman of the Board Enters retention agreements with executive leadership to […]
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the […]
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
Late-breaking presentation of data at American Transplant Congress on Monday, June 3 Data show potential to monitor for therapeutic efficacy […]
SAB Biotherapeutics Announces Departure of Chief Financial Officer
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with […]
